Zinger Key Points
- BofA upgrades Dow, eyes 50% EBITDA growth by 2025.
- Overall, for U.S/ chemicals stocks, the analyst moderately reduces earnings estimates.
- The new Benzinga Rankings show you exactly how stocks stack up—scoring them across five key factors that matter most to investors. Every day, one stock rises to the top. Which one is leading today?
BofA Securities analyst Steve Byrne said he was bullish on commodity chemical stocks but remained selective given a tough recovery and leans “this way with lithium, as well.”
The analyst expected residential and non-resi investments to remain soft, with more resilience in aerospace and auto and a continued focus on decarbonization and water management.
Consequently, the analyst issued an upgrade for Dow Inc DOW to Buy from Hold with an increased price target of $60 from $57, expecting the company to witness EBITDA growth of ~50% by 2025 (vs. 2023).
On the other hand, the analyst gave Celanese Corporation CE a downgrade to Underperform from Neutral with an increased price target of $135 from $124. Given the 56% return in 2023, he sees the shares more than fully discount the expected earnings recovery.
Apart from this, the analyst stated the agricultural (ag) markets are entering normalized earnings at a lower part of the cycle, with farmer margins expected to be flat Y/Y in 2024 but still above pre-2021 levels.
As the outlook for crop chemicals remains sluggish, the analyst downgraded FMC Corp FMC to Underperform from Neutral with a lowered price target of $57 from $60 on lack of conviction about a near-term earnings recovery.
Among the other petrochemical/diversified companies, the analyst lowered the rating on DuPont de Nemours Inc DD to Underperform from Buy with a higher price target of $80 from $78, reflecting modest earnings recovery in 2024 and under-appreciated PFAS liabilities.
Meanwhile, the analyst issued an upgrade for Ecolab Inc ECL to Neutral from Underperform and raised the price target to $216 from $185 on expected continued benefit from aggressive pricing, business wins, cost deflation and focus on productivity.
Overall, for U.S/ chemicals stocks, the analyst moderately reduced the earnings estimates, with EPS lowered by an average of 3% for the fourth quarter of FY23 and 6% for FY24.
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.